Navigation Links
Cempra, Inc. to Present at Oppenheimer 23rd Annual Healthcare Conference
Date:12/5/2012

CHAPEL HILL, N.C., Dec. 5, 2012 /PRNewswire/ -- Cempra, Inc. (Nasdaq: CEMP) today announced that Prabhavathi Fernandes, Ph.D., president and chief executive officer of Cempra, will present at the Oppenheimer 23rd Annual Healthcare Conference at 11:10 a.m. EST, Wednesday, Dec. 12, at the Waldorf=Astoria in New York City. Dr. Fernandes will provide an update of the company's two leading antibiotic clinical programs, solithromycin (CEM-101) for community-acquired bacterial pneumonia and its fusidic acid (CEM-102) for the chronic, oral treatment of gram positive pathogens including methicillin-resistant S. aureus (MRSA) in prosthetic joint infections.

The presentation at the Oppenheimer 23rd Annual Healthcare Conference will be webcast live under the events section of Cempra's website at www.cempra.com and will be archived there following the presentation. Please connect to Cempra's website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary.

About Cempra, Inc.
Founded in 2006, Cempra, Inc. is a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases. Cempra's two lead product candidates have both completed oral Phase 2 clinical trials and seek to address the need for new treatments targeting drug-resistant bacterial infections in the hospital and in the community. The company also intends to utilize its series of proprietary lead compounds from its novel macrolide library for uses such as the treatment of chronic inflammatory diseases, endocrine diseases and gastric motility disorders. Additional information about Cempra can be found at www.cempra.com.

Investor and Media Contacts:
Robert E. Flamm, Ph.D.
Russo Partners, LLC
(212) 845-4226 
Robert.flamm@russopartnersllc.com

Andreas Marathovouniotis
Russo Partners, LLC
(212) 845-4235
Andreas.marathis@russopartnersllc.com


'/>"/>
SOURCE Cempra, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Cempra, Inc. to Present at the Jefferies 2012 Global Healthcare Conference in London
2. Cempra, Inc. to Report Third Quarter 2012 Financial and Operating Results, and Host Conference Call and Webcast on November 8, 2012
3. Cempra, Inc., to Present at 2012 Stifel Nicolaus Healthcare Conference and NewsMakers in the Biotech Industry Conference
4. Cempra, Inc. Reports Second Quarter 2012 Financial and Operating Results
5. Cempra, Inc. to Present at the NIAID Workshop Bridging the Gap - Overcoming Bottlenecks in the Development of Therapeutics for Infectious Diseases
6. Cempra, Inc. to Report Second Quarter 2012 Financial and Operating Results, and Host Conference Call and Webcast on August 8, 2012
7. Cempra, Inc. to Present at the Global Technology Community 9th Anti-Infectives Partnering and Deal-Making Conference
8. Cempra, Inc. to Report First Quarter 2012 Financial and Operating Results, and Host Conference Call and Webcast on May 10, 2012
9. Regado Biosciences, Inc. to Present at the Oppenheimer 23rd Annual Healthcare Conference in New York, NY
10. Optimer Pharmaceuticals to Present at 23rd Annual Oppenheimer Healthcare Conference
11. PAREXEL International To Present At Oppenheimer Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2020)... LONDON, CT (PRWEB) , ... June 25, 2020 ... ... yet again on Connecticut Magazine’s 2020 Top Dentist list within the Periodontics category. ... two practice locations in New London, CT and Westerly, RI. Laser gum disease ...
(Date:6/24/2020)... ... June 24, 2020 , ... People curious about chiropractic medicine ... County Line Chiropractic’s YouTube channel. Dr. Vivian Solivan, one of County Line ... locations in the South Florida area, including the Lauderhill office, where Dr. Solivan ...
(Date:6/23/2020)... ... June 23, 2020 , ... Draper today announced the release ... used to test an in vitro human lung model to investigate responses following ... Draper and the University of Massachusetts Medical School . The ...
Breaking Medicine Technology:
(Date:6/28/2020)... Calif. (PRWEB) , ... June 26, 2020 , ... ... tougher. Inland Detox, the Inland Empire’s premier residential addiction treatment center, proudly announces ... services that now includes special preparation for recovery in a world affected by ...
(Date:6/28/2020)... Mass. (PRWEB) , ... June 27, 2020 , ... ... FSHD Connect Classroom, the first online, full-day educational conference in the organization’s history. ... meeting for facioscapulohumeral muscular dystrophy (FSHD), which was cancelled this year due to ...
(Date:6/25/2020)... ... June 25, 2020 , ... Denials Management, Inc. has just ... key steps when filing appeals for denials of mental health and substance use disorder ... individuals about their appeal rights and explain the steps in the appeals process. ...
(Date:6/24/2020)... Ark. (PRWEB) , ... June 24, 2020 , ... Dr. ... program, has been the most requested guest on the True Grit and Grace podcast. ... to have hope and knowing remission is possible. , After being diagnosed with ...
(Date:6/24/2020)... (PRWEB) , ... June 24, 2020 , ... Skyroam ... today a partnership with LabWare , the leading provider of enterprise software for ... WiFi connectivity as part of LabWare’s new Portable Disease Surveillance Lab (PDSL) kit. , ...
Breaking Medicine News(10 mins):